LeonaBio Inc
LONA
98 hedge funds and large institutions have $68M invested in LeonaBio Inc in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 23 reducing their positions, and 27 closing their positions.
156% more call options, than puts
Call options by funds: $12.8M | Put options by funds: $5.01M
61% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 23
1.13% less ownership
Funds ownership: 7% → 5.87% (-1.1%)
7% less funds holding
Funds holding: 105 → 98 (-7)
19% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 27
82% less capital invested
Capital invested by funds: $382M → $68M (-$314M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$17.2M |
| 2 |
PA
Perceptive Advisors
New York
|
+$12.6M |
| 3 |
Goldman Sachs
New York
|
+$4.59M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$2.15M |
| 5 |
Two Sigma Investments
New York
|
+$1.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$27M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$26.6M |
| 3 |
RI
RTW Investments
New York
|
-$25.7M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$17.2M |
| 5 |
VA
VR Adviser
New York
|
-$13.5M |
LONA Hedge Fund Activity: Q2 2022 in Review
98 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in LeonaBio Inc (LONA) for Q2 2022, worth a combined $68M — down 82% from $382M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of LONA and 22 opened new positions — a net loss of 5 holders — while 23 trimmed existing stakes and 37 added.
The largest buyer was RA Capital Management, opening a new position worth an estimated $17.2M. The largest seller was Silverarc Capital Management, exiting entirely with an estimated $27M sold.
- 98 institutional investors held LeonaBio Inc (LONA) as of Q2 2022, down from 105 in Q1 2022.
- Funds reported $68M of LeonaBio Inc stock for Q2 2022, down 82% quarter-over-quarter.
- 22 funds opened new LeonaBio Inc positions in Q2 2022 and 27 closed out, a net change of -5 holders.
- The largest LeonaBio Inc buyer in Q2 2022 was RA Capital Management, an estimated $17.2M added.
- The largest LeonaBio Inc seller in Q2 2022 was Silverarc Capital Management, an estimated $27M sold.
Based on aggregated 13F filings for Q2 2022.